EMA Says It Is Assessing Reported Menstrual Issues With Comirnaty, Spikevax Shots
T-Reuters2022-02-11
European Medicines Agency:Ema: Prac Assessing Reported Cases Of Heavy Menstrual Bleeding & Absence Of Menstruation With Covid-19 Vaccines Comirnaty And Spikevax.Ema Says Prac Decided To Request An In-Depth Evaluation Of All Available Data On Period Irregularities, Including Reports From Spontaneous Reporting Systems.Ema - At This Stage, It Is Not Yet Clear Whether There Is A Causal Link Between The Covid-19 Vaccines And The Reports Of Heavy Periods Or Amenorrhea.Ema - No Evidence To Suggest That Covid-19 Vaccines Affect Fertility..Ema Starts Safety Review Of Janus Kinase Inhibitors For Inflammatory Disorders.Further Company Coverage: Mrna.O. ((Reuters.Briefs@Thomsonreuters.Com;)).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.